Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Open in API
Filings indexed 1,031 across all filing types
Latest filing 2019-12-13 Proxy Solicitation & In…
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
OXUR Proxy 2ndEGM Dec2019 EN.pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is explicitly titled "PROXY" and details the process for a shareholder to appoint a representative (Proxy Holder) for an "extraordinary shareholders' meeting" scheduled for December 30, 2019. It outlines the agenda, which includes resolutions for capital decrease and amending articles of association, and provides voting options ('Agreed', 'Not agreed', 'Abstention'). This material is directly related to soliciting shareholder votes and providing information for a general meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). Although it relates to an extraordinary meeting, the core function is proxy solicitation.
2019-12-13 English
OXUR Proxy 2ndEGM Dec2019 NL.pdf
AGM Information Classification · 98% confidence The document is titled 'VOLMACHT' (Proxy) and explicitly details the process for a shareholder to appoint a representative ('Gevolmachtigde') to attend and vote at an 'buitengewone algemene vergadering' (Extraordinary General Meeting - EGM) scheduled for December 30, 2019. It includes sections for shareholder details, proxy appointment, and the agenda with proposed resolutions (including capital reduction and statute amendments). This document is the formal instrument used to grant voting rights for a general meeting, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI), as it is a form used to solicit or formalize voting instructions/representation for a meeting. It is not the AGM presentation itself (AGM-R), nor is it a general regulatory announcement (RNS) or a report (10-K, IR).
2019-12-13 Dutch
OXUR ConveningNotice 2ndEGM Dec2019 EN.pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is explicitly titled 'CONVOCATION OF THE EXTRAORDINARY GENERAL SHAREHOLDERS' MEETING' and details the agenda, proposed resolutions (including capital decrease and amendment of articles of association), quorum requirements, and procedures for participation and voting for a second meeting scheduled for December 30, 2019. This content is characteristic of materials sent to shareholders to solicit their vote or inform them about a meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). While it relates to an AGM/EGM, the focus is on the formal convocation and voting mechanics, making PSI a more precise fit than AGM-R (which is usually the presentation materials *from* the meeting).
2019-12-13 English
OXUR ConveningNotice 2ndEGM Dec2019 NL.pdf
AGM Information Classification · 98% confidence The document is explicitly titled "OPROEPING TOT BUITENGEWONE ALGEMENE VERGADERING VAN AANDEELHOUDERS" (Call for Extraordinary General Meeting of Shareholders). It details the agenda for a second EGM, including proposals for capital reduction and statutory amendments, and outlines procedures for participation, voting, and proxy submission. This content directly relates to the formal process and materials surrounding a shareholder meeting, fitting the definition of AGM Information (AGM-R). Although it is a call/notice rather than the final voting results (DVA), the primary focus is the meeting itself.
2019-12-13 Dutch
OXUR Proxy EGM Dec2019 (NL English).pdf
AGM Information Classification · 98% confidence The document is explicitly titled 'VOLMACHT' (Proxy) in Dutch and 'PROXY' in English. It details the process for a shareholder to appoint a representative ('Gevolmachtigde'/'Proxy Holder') to vote at an 'buitengewone algemene vergadering' (extraordinary general meeting) scheduled for December 13, 2019. The agenda includes proposals for capital reduction and amending articles of association. This document is a form used to grant voting rights for a general meeting, which falls under the scope of materials related to shareholder meetings and voting instructions. The most appropriate category is AGM-R (AGM Information), as it is directly related to the mechanics of attending and voting at a general meeting, even though it is an extraordinary one, not the annual one. It is not the minutes (AGM-R might cover minutes, but this is the authorization form), nor is it a declaration of voting results (DVA). Given the context of proxy forms for shareholder meetings, AGM-R is the best fit among the provided options.
2019-11-14 English
OXUR EGM Dec2019 SpecialBoardReport (NL English).pdf
Capital/Financing Update Classification · 99% confidence The document is explicitly titled "BIJZONDER VERSLAG VAN DE RAAD VAN BESTUUR OVEREENKOMSTIG ARTIKEL 7:228 VAN HET WETBOEK VAN VENNOOTSCHAPPEN EN VERENIGINGEN" (Special Report of the Board of Directors in accordance with Article 7:228 of the Belgian Companies and Associations Code). This report addresses a situation where net assets have fallen below half of the share capital, requiring the Board to propose action (dissolution or recovery measures) to an extraordinary general meeting. This type of mandatory report detailing financial distress and proposed capital restructuring measures (like capital reduction to absorb losses) is a specific corporate governance/financing disclosure. It is not a standard Annual Report (10-K), Interim Report (IR), or simple Earnings Release (ER). Since it deals with capital structure changes proposed due to financial distress, it strongly relates to Capital/Financing Update (CAP) or potentially Governance Information (CGR). However, the core purpose is to present a formal proposal regarding the company's capital structure and continuation based on legal requirements, making 'CAP' the most fitting category among the provided options, as it directly concerns capital structure remediation. It is a formal report, not just an announcement of a report (RPA/RNS).
2019-11-14 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.